Two honest caveats: compounded GLP-1 medications are not FDA-approved, and we have an affiliate relationship with SkinnyRx weigh both when deciding
How It Works: Polyphenols can bind to the DPP-4 enzymes active site or alter its conformational structure, reducing its ability to cleave GLP-1
Retatrutide versus other weight loss peptides Compared to semaglutide: Semaglutide targets only GLP-1 receptors, achieving approximately 15-17% weight loss in clinical trials
In a standard U-100 insulin syringe, 100 units equal 1 milliliter (mL)
Omeprazole is not listed as a contraindication or a flagged interaction on the Wegovy label, and the manufacturer's own pharmacokinetic testing found no clinically significant differences in semaglutide exposure when the two were given together but "no known interaction" is not the same as "no reason to tell your prescriber," and the reason people ask this question at all is worth unpacking
PlexusDx recommends discussing your genetic profile, weight loss timeline, and personal goals before making long-term therapy decisions